Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China flag China · Delayed Price · Currency is CNY
17.76
-0.99 (-5.28%)
Apr 21, 2026, 3:00 PM CST
Market Cap7.89B +100.3%
Revenue (ttm)719.17M +72.1%
Net Income-19.53M
EPS-0.05
Shares Out420.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,994,955
Average Volume16,110,815
Open18.57
Previous Close18.75
Day's Range17.55 - 18.68
52-Week Range10.01 - 22.55
Beta0.51
RSI49.34
Earnings DateMar 31, 2026

About SHA:688488

Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally. The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 735
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688488
Full Company Profile

Financial Performance

In 2025, SHA:688488's revenue was 719.17 million, an increase of 72.13% compared to the previous year's 417.80 million. Losses were -19.53 million, -86.17% less than in 2024.

Financial Statements